High risk of acute pulmonary toxicity with both myeloablative and non-myeloablative total body irradiation-based conditioning for allogeneic stem cell transplantation

Bone Marrow Transplant. 2024 Jan;59(1):150-152. doi: 10.1038/s41409-023-02140-y. Epub 2023 Nov 3.

Authors

Pranalee Patel¹, Mairead Dillon², Donna Niedzwiecki², Kerri-Anne Crowell², Mitchell E Horwitz³, Edina Wang¹, Chris R Kelsey⁴

Affiliations

¹ Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27710, USA.
² Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, 27710, USA.
³ Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, 27710, USA.
⁴ Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27710, USA. [email protected].

PMID: 37923832
DOI: 10.1038/s41409-023-02140-y

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cyclophosphamide
Graft vs Host Disease* / etiology
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Myeloablative Agonists
Neoplasm Recurrence, Local
Retrospective Studies
Transplantation Conditioning / adverse effects
Whole-Body Irradiation / adverse effects

Substances

Cyclophosphamide
Myeloablative Agonists